Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Overview
Company Headquarters: Nanjing, China
Founded: 1969
Workforce: ~ 1,800
Company Working: Chia Tai Tianqing Pharmaceutical Group Co. produces and manufactures pharmaceutical products. The company sells drugs for diseases like diabetes, liver disease, cancer, cardiovascular disease, anti-infective, digestion problems, and respiratory problems. Chia Tai Tianqing Pharmaceutical Group distributes its products domestically and internationally. With GMP-based clearance from the US FDA and EU Health Authority, as well as specialized and diversified products in development, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), one of the top 30 pharmaceutical companies in China, anticipates being more active in foreign business. In addition, it operates s as a subsidiary of Sino Biopharmaceutical Limited. It has 3 manufacturing plants focusing on FDF and API production, 2 R&D centers, 1 overseas branch (CTTQ EU) in Barcelona, Spain, 1 business development office in San Diego, USA, and 4 joint labs (in Shanghai and Chengdu).
Strategy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is committed to innovation and study of products that have production or technological barriers in order to elevate people's quality of life and progress human health. Moreover, the company's growth strategy is built on introducing superior items based on scientific advancements. In addition, the company is planning to usher in a digital revolution by using digital technologies, advanced analytics, and artificial intelligence to help boost innovation and efficiency.
